Download FREE Report Sample
Download Free sampleRapid tests are often referred to as point-of-care tests because rather than sending a blood sample to a laboratory, the test can be conducted and the result read in a doctor?s office or a community setting, without specialised laboratory equipment. The sample taken is usually either finger-prick blood or saliva.
Rapid Disease Tests Market contains market size and forecasts of Rapid Disease Tests in Global, including the following market information:
Global Rapid Disease Tests Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Rapid Disease Tests market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Over-the-counter (OTC) Rapid Test Product Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Rapid Disease Tests include Becton, Dickinson and Company, Bio-Rad Laboratories, Thermo Fisher Scientific, Akers Biosciences, Inc., Abbott, Cepheid, Inc., Hologic, Inc., Meridian Bioscience, Inc. and OraSure Technologies, Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Rapid Disease Tests companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Rapid Disease Tests Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Rapid Disease Tests Market Segment Percentages, by Type, 2021 (%)
Over-the-counter (OTC) Rapid Test Product
Professional Rapid Test Product
Global Rapid Disease Tests Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Rapid Disease Tests Market Segment Percentages, by Application, 2021 (%)
Infectious Disease
Cardiology
Oncology
Pregnancy and Fertility
Toxicology
Glucose Monitoring
Others
Global Rapid Disease Tests Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Rapid Disease Tests Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Rapid Disease Tests revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Rapid Disease Tests revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Becton, Dickinson and Company
Bio-Rad Laboratories
Thermo Fisher Scientific
Akers Biosciences, Inc.
Abbott
Cepheid, Inc.
Hologic, Inc.
Meridian Bioscience, Inc.
OraSure Technologies, Inc.
Quidel Corporation
Roche Diagnostics
Creative Diagnostics
Cardinal Health
RayBiotech
Guangzhou Wondfo Biotech
Sinocare
Maccura Biotechnology Co
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
